Skip to main content

Market Overview

Recap: Motus GI Hldgs Q1 Earnings


Shares of Motus GI Hldgs (NASDAQ:MOTS) fell in after-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share increased 52.17% year over year to ($0.11), which missed the estimate of ($0.10).

Revenue of $51,000 rose by 82.14% year over year, which beat the estimate of $30,000.


Motus GI Hldgs hasn't issued any earnings guidance for the time being.

Motus GI Hldgs hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: May 13, 2021

Time: 04:30 PM

ET Webcast URL:

Recent Stock Performance

Company's 52-week high was at $2.74

Company's 52-week low was at $0.68

Price action over last quarter: down 41.30%

Company Overview

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company is focused on the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.


Related Articles (MOTS)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings